Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma
Authors
Keywords
Clear cell renal cell carcinoma, Survivin, HLA class I molecules, Immunohistochemistry, Prognosis
Journal
TUMOR BIOLOGY
Volume 35, Issue 8, Pages 8281-8288
Publisher
Springer Nature
Online
2014-05-23
DOI
10.1007/s13277-014-2058-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma
- (2012) Jinyang Yuan et al. ACTA HISTOCHEMICA
- Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer
- (2012) Emilia Andersson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel Foxo1-dependent transcriptional programs control Treg cell function
- (2012) Weiming Ouyang et al. NATURE
- Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor
- (2011) Daniela Montagna et al. CYTOTHERAPY
- Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation
- (2011) Juliane S Stickel et al. BMC Urology
- Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
- (2010) Bradley C. Leibovich et al. JOURNAL OF UROLOGY
- Development and evaluation of BioScore
- (2009) Alexander S. Parker et al. CANCER
- Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels
- (2009) D. Mahalingam et al. CLINICAL CANCER RESEARCH
- Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
- (2009) J. Lu et al. CLINICAL CANCER RESEARCH
- Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer
- (2009) C. Xiaoyuan et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer
- (2009) Shin-ichi Yamashita et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness
- (2009) Giueng-Chueng Wang et al. WORLD JOURNAL OF UROLOGY
- Survivin Expression in Renal Cell Carcinoma
- (2008) Rosanna Zamparese et al. CANCER INVESTIGATION
- Cancer cells survive with survivin
- (2008) Hirofumi Yamamoto et al. CANCER SCIENCE
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma
- (2008) Alexander S. Parker et al. HUMAN PATHOLOGY
- A simple and effective method for cancer immunotherapy by inactivated allogeneic leukocytes infusion
- (2008) Xiaosan Su et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started